Atomoxetine is a sympathomimetic that acts as a noradrenaline reuptake inhibitor. The manufacturers therefore predict that it may have additive or synergistic pharmacological effects with other drugs that affect noradrenaline, such as
venlafaxine.
The manufacturer recommends caution. Be aware that additive effects are possible and monitor e.g. somnolence or agitation, as appropriate.